|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2022―Oct―24 |
Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summary |
Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout |
2 |
[GO] |
2021―Dec―02 |
COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report |
Gooya Tayyebi, Seyed Kazem Malakouti, Behnam Shariati, Leila Kamalzadeh |
3 |
[GO] |
2021―Jul―21 |
A survey on patients' disease perception and the impact of the COVID-19 pandemic on persons living with amyotrophic lateral sclerosis in Malaysia |
Suzanna Edgar, Nur Adilah Abdul-Aziz, Ee Chin Loh, David Capelle, Khean-Jin Goh, Lydia Abdul Latif, Nortina Shahrizaila, Azlina Ahmad-Annuar |
4 |
[GO] |
2020―Nov―11 |
Cognitive testing in the COVID-19 era: can existing screeners be adapted for telephone use? |
Andrew J Larner |